JP2010532390A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010532390A5 JP2010532390A5 JP2010515339A JP2010515339A JP2010532390A5 JP 2010532390 A5 JP2010532390 A5 JP 2010532390A5 JP 2010515339 A JP2010515339 A JP 2010515339A JP 2010515339 A JP2010515339 A JP 2010515339A JP 2010532390 A5 JP2010532390 A5 JP 2010532390A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- group
- eudragit
- registered trademark
- sensitive adhesive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 48
- 239000011159 matrix material Substances 0.000 claims 24
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 claims 21
- 239000004820 Pressure-sensitive adhesive Substances 0.000 claims 20
- 229920003134 Eudragit® polymer Polymers 0.000 claims 19
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims 18
- KFQYTPMOWPVWEJ-INIZCTEOSA-N rotigotine Chemical compound CCCN([C@@H]1CC2=CC=CC(O)=C2CC1)CCC1=CC=CS1 KFQYTPMOWPVWEJ-INIZCTEOSA-N 0.000 claims 16
- 229960003179 rotigotine Drugs 0.000 claims 16
- 239000000178 monomer Substances 0.000 claims 14
- 229920001296 polysiloxane Polymers 0.000 claims 11
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 9
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims 9
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 9
- -1 fatty acids azone compounds Chemical class 0.000 claims 8
- 229920000642 polymer Polymers 0.000 claims 8
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims 6
- 239000010410 layer Substances 0.000 claims 6
- 238000010521 absorption reaction Methods 0.000 claims 5
- 239000003623 enhancer Substances 0.000 claims 5
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims 4
- 239000004925 Acrylic resin Substances 0.000 claims 4
- 229920000178 Acrylic resin Polymers 0.000 claims 4
- SOGAXMICEFXMKE-UHFFFAOYSA-N Butylmethacrylate Chemical compound CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 claims 4
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 claims 4
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims 4
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical group CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 claims 4
- CQEYYJKEWSMYFG-UHFFFAOYSA-N butyl acrylate Chemical compound CCCCOC(=O)C=C CQEYYJKEWSMYFG-UHFFFAOYSA-N 0.000 claims 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims 4
- DXPPIEDUBFUSEZ-UHFFFAOYSA-N 6-methylheptyl prop-2-enoate Chemical compound CC(C)CCCCCOC(=O)C=C DXPPIEDUBFUSEZ-UHFFFAOYSA-N 0.000 claims 3
- 235000014113 dietary fatty acids Nutrition 0.000 claims 3
- 229940079593 drug Drugs 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 150000002148 esters Chemical class 0.000 claims 3
- 239000000194 fatty acid Substances 0.000 claims 3
- 229930195729 fatty acid Natural products 0.000 claims 3
- 125000000524 functional group Chemical group 0.000 claims 3
- 239000003960 organic solvent Substances 0.000 claims 3
- 239000004094 surface-active agent Substances 0.000 claims 3
- 235000007586 terpenes Nutrition 0.000 claims 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims 2
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical compound CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 claims 2
- GOXQRTZXKQZDDN-UHFFFAOYSA-N 2-Ethylhexyl acrylate Chemical compound CCCCC(CC)COC(=O)C=C GOXQRTZXKQZDDN-UHFFFAOYSA-N 0.000 claims 2
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 claims 2
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical group CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 claims 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims 2
- 229920003079 Povidone K 17 Polymers 0.000 claims 2
- 229920003080 Povidone K 25 Polymers 0.000 claims 2
- 229920003081 Povidone K 30 Polymers 0.000 claims 2
- 239000003655 absorption accelerator Substances 0.000 claims 2
- 150000001298 alcohols Chemical class 0.000 claims 2
- 239000002131 composite material Substances 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 239000004148 curcumin Substances 0.000 claims 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 claims 2
- SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 claims 2
- 150000004665 fatty acids Chemical class 0.000 claims 2
- 125000003055 glycidyl group Chemical group C(C1CO1)* 0.000 claims 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims 2
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 claims 2
- 229920000191 poly(N-vinyl pyrrolidone) Polymers 0.000 claims 2
- 229960004889 salicylic acid Drugs 0.000 claims 2
- FILVIKOEJGORQS-UHFFFAOYSA-N 1,5-dimethylpyrrolidin-2-one Chemical compound CC1CCC(=O)N1C FILVIKOEJGORQS-UHFFFAOYSA-N 0.000 claims 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical group O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 claims 1
- ODHCTXKNWHHXJC-UHFFFAOYSA-N 5-oxoproline Chemical compound OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 claims 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 1
- 229920003119 EUDRAGIT E PO Polymers 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 1
- 229920003156 Eudragit® RL PO Polymers 0.000 claims 1
- 229920003160 Eudragit® RS PO Polymers 0.000 claims 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 claims 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 claims 1
- 239000005639 Lauric acid Substances 0.000 claims 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical group CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims 1
- 229930003427 Vitamin E Natural products 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 230000000996 additive effect Effects 0.000 claims 1
- 239000003963 antioxidant agent Substances 0.000 claims 1
- 230000003078 antioxidant effect Effects 0.000 claims 1
- 235000006708 antioxidants Nutrition 0.000 claims 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 claims 1
- 239000012458 free base Substances 0.000 claims 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 229940065472 octyl acrylate Drugs 0.000 claims 1
- 230000003647 oxidation Effects 0.000 claims 1
- 238000007254 oxidation reaction Methods 0.000 claims 1
- 239000011241 protective layer Substances 0.000 claims 1
- 150000004040 pyrrolidinones Chemical class 0.000 claims 1
- 229960001860 salicylate Drugs 0.000 claims 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 claims 1
- 150000003505 terpenes Chemical class 0.000 claims 1
- 235000019165 vitamin E Nutrition 0.000 claims 1
- 229940046009 vitamin E Drugs 0.000 claims 1
- 239000011709 vitamin E Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200710118491XA CN101147739B (zh) | 2007-07-06 | 2007-07-06 | 含罗替戈汀的组合物及其制药用途以及含该组合物的透皮贴剂 |
| CN200710118491.X | 2007-07-06 | ||
| PCT/CN2008/001267 WO2009006787A1 (en) | 2007-07-06 | 2008-07-03 | Composition comprising rotigotine, its use and transdermal patch comprising the composition |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010532390A JP2010532390A (ja) | 2010-10-07 |
| JP2010532390A5 true JP2010532390A5 (enExample) | 2011-07-21 |
| JP4883220B2 JP4883220B2 (ja) | 2012-02-22 |
Family
ID=39248511
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010515339A Active JP4883220B2 (ja) | 2007-07-06 | 2008-07-03 | ロチゴチン含有組成物及びその使用並びにこの組成物を含む経皮貼付剤 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US9265752B2 (enExample) |
| EP (1) | EP2177217B1 (enExample) |
| JP (1) | JP4883220B2 (enExample) |
| CN (1) | CN101147739B (enExample) |
| DK (1) | DK2177217T3 (enExample) |
| ES (1) | ES2655705T3 (enExample) |
| WO (1) | WO2009006787A1 (enExample) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101147739B (zh) | 2007-07-06 | 2010-12-08 | 北京康倍得医药技术开发有限公司 | 含罗替戈汀的组合物及其制药用途以及含该组合物的透皮贴剂 |
| TWI541246B (zh) | 2008-12-08 | 2016-07-11 | 歐陸斯迪公司 | 二氫羥戊甲嗎啡 |
| WO2011048491A2 (en) | 2009-10-19 | 2011-04-28 | Actavis Group Ptc Ehf | Amorphous rotigotine co-precipitates |
| JP5815556B2 (ja) | 2009-12-22 | 2015-11-17 | ウーツェーベー ファルマ ゲーエムベーハーＵｃｂ Ｐｈａｒｍａ Ｇｍｂｈ | 非結晶形態のロチゴチンの固体分散体を安定化するためのポリビニルピロリドン |
| WO2012084969A1 (en) | 2010-12-22 | 2012-06-28 | Hexal Ag | Adhesive composition containing rotigotine and transdermal therapeutic system comprising the adhesive composition |
| JP5900971B2 (ja) * | 2011-02-02 | 2016-04-06 | 大日本住友製薬株式会社 | 経皮吸収促進剤及びそれを含有する経皮吸収型製剤 |
| JP5856424B2 (ja) * | 2011-10-05 | 2016-02-09 | 祐徳薬品工業株式会社 | ロチゴチン含有経皮吸収型貼付剤 |
| DE102012205493A1 (de) * | 2012-04-03 | 2013-10-10 | Acino Ag | Einen Dopamin-Agonisten enthaltendes transdermales Applikationssystem |
| KR101558042B1 (ko) * | 2012-07-05 | 2015-10-07 | 에스케이케미칼주식회사 | 로티고틴을 함유한 경피흡수제제 |
| CN105247002B (zh) * | 2012-11-19 | 2018-02-06 | 瀚森公司 | 压敏粘结剂组合物 |
| TW201431570A (zh) | 2012-11-22 | 2014-08-16 | Ucb Pharma Gmbh | 用於經皮投服羅替戈汀（Ｒｏｔｉｇｏｔｉｎｅ）之多天式貼片 |
| EP2968201B1 (en) | 2013-03-13 | 2022-12-28 | Avery Dennison Corporation | Enhanced drug delivery from adhesives |
| WO2014159798A1 (en) | 2013-03-13 | 2014-10-02 | Avery Dennison Corporation | Improving adhesive properties |
| AR095259A1 (es) * | 2013-03-15 | 2015-09-30 | Noven Pharma | Composiciones y métodos para la administración transdérmica de fármacos de amina terciaria |
| KR101686987B1 (ko) * | 2013-05-30 | 2016-12-15 | 에스케이케미칼주식회사 | 로티고틴과 지방산 및 스티렌 점착제를 함유한 경피치료시스템 |
| GB201309654D0 (en) | 2013-05-30 | 2013-07-17 | Euro Celtique Sa | Method |
| WO2015001012A1 (de) | 2013-07-03 | 2015-01-08 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches system mit elektronischem bauteil |
| GB201317718D0 (en) | 2013-10-07 | 2013-11-20 | Buzzz Pharmaceuticals Ltd | Novel formulation |
| WO2015168646A1 (en) * | 2014-05-02 | 2015-11-05 | The Research Foundation For The State University Of New York | Compositions and methods for intradermal vaccine delivery |
| CA2948220C (en) * | 2014-05-20 | 2023-06-20 | Lts Lohmann Therapie-Systeme Ag | Transdermal delivery system containing rotigotine |
| EP3145503A1 (en) | 2014-05-20 | 2017-03-29 | LTS Lohmann Therapie-Systeme AG | Method for adjusting the release of active agent in a transdermal delivery system |
| CA2948221C (en) | 2014-05-20 | 2022-11-22 | Lts Lohmann Therapie-Systeme Ag | Transdermal delivery system including an interface mediator |
| KR102364378B1 (ko) * | 2014-05-21 | 2022-02-16 | 에스케이케미칼 주식회사 | 안정성을 향상시킨 로티고틴 함유 경피흡수제제 |
| DE102014114282A1 (de) * | 2014-10-01 | 2016-04-07 | Neuraxpharm Arzneimittel Gmbh | Transdermales therapeutisches System mit Rotigotin zur Behandlung von Morbus Parkinson |
| GB201520647D0 (en) * | 2015-11-23 | 2016-01-06 | Buzzz Pharmaceuticals Ltd | Transdermal patches |
| WO2017153441A1 (en) * | 2016-03-09 | 2017-09-14 | Tesa Labtec Gmbh | Topical composition |
| WO2018067163A1 (en) | 2016-10-07 | 2018-04-12 | Transwell Biotech Co., Ltd. | Pramipexole transdermal delivery system and uses thereof |
| EP3700511A1 (en) | 2017-10-17 | 2020-09-02 | Lubrizol Advanced Materials, Inc. | Composition and device for delivery of active agents to skin surfaces |
| CN107823190A (zh) * | 2017-11-06 | 2018-03-23 | 广州市桐晖药业有限公司 | 一种盐酸洛哌丁胺贴剂 |
| CN110292576A (zh) * | 2019-07-01 | 2019-10-01 | 武汉威立得生物医药有限公司 | 罗替戈汀在制备治疗或预防流感病毒感染的药物中的应用 |
| CN112076177B (zh) * | 2020-10-28 | 2021-08-31 | 江苏集萃新型药物制剂技术研究所有限公司 | 一种口腔粘膜给药系统 |
| CN112891324A (zh) * | 2021-01-19 | 2021-06-04 | 北京亚宝生物药业有限公司 | 一种透皮贴剂 |
| CN117157044A (zh) * | 2021-04-06 | 2023-12-01 | Ddp特种电子材料美国第9有限公司 | 成膜组合物 |
| CN113368083A (zh) * | 2021-06-16 | 2021-09-10 | 华健医疗(深圳)有限公司 | 一种大麻二酚cbd透皮给药系统 |
| CN113384560A (zh) * | 2021-07-07 | 2021-09-14 | 华健医疗(深圳)有限公司 | 一种治疗或预防神经系统疾病的罗替戈汀与尼古丁的复方透皮贴片及制备方法 |
| CN114699391B (zh) * | 2022-04-07 | 2023-10-31 | 北京福元医药股份有限公司 | 一种罗替高汀透皮吸收贴剂 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5474783A (en) * | 1988-03-04 | 1995-12-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
| US5656286A (en) | 1988-03-04 | 1997-08-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
| CN1151780C (zh) * | 1993-01-02 | 2004-06-02 | 诺纹制药股份有限公司 | 基于溶度参数的药物释放系统和改变药物饱和浓度的方法 |
| DE19814084B4 (de) * | 1998-03-30 | 2005-12-22 | Lts Lohmann Therapie-Systeme Ag | D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung |
| US20020004065A1 (en) * | 2000-01-20 | 2002-01-10 | David Kanios | Compositions and methods to effect the release profile in the transdermal administration of active agents |
| EP1344522A1 (en) | 2001-05-08 | 2003-09-17 | Schwarz Pharma Ag | Transdermal therapeutic system for Parkinson's disease inducing high plasma levels of rotigotine |
| TWI277418B (en) * | 2001-06-18 | 2007-04-01 | Noven Pharma | Enhanced drug delivery in transdermal systems |
| US20060216336A1 (en) * | 2002-05-07 | 2006-09-28 | Hans-Michael Wolff | Transdermal therapeutic system for Parkinson's Disease |
| DE10234673B4 (de) * | 2002-07-30 | 2007-08-16 | Schwarz Pharma Ag | Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren |
| DE10261696A1 (de) * | 2002-12-30 | 2004-07-15 | Schwarz Pharma Ag | Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base |
| DE10361259A1 (de) | 2003-12-24 | 2005-07-28 | Schwarz Pharma Ag | Verwendung von Rotigotine in einem Frühstadium von Morbus Parkinson zur Prävention des weiteren Neuronenverlustes |
| CN100411692C (zh) | 2004-01-13 | 2008-08-20 | 北京康倍得医药技术开发有限公司 | 丙烯酸基粘合剂组合物及其药物组合物和透皮治疗系统 |
| CN101147739B (zh) * | 2007-07-06 | 2010-12-08 | 北京康倍得医药技术开发有限公司 | 含罗替戈汀的组合物及其制药用途以及含该组合物的透皮贴剂 |
-
2007
- 2007-07-06 CN CN200710118491XA patent/CN101147739B/zh active Active
-
2008
- 2008-07-03 EP EP08773014.9A patent/EP2177217B1/en active Active
- 2008-07-03 JP JP2010515339A patent/JP4883220B2/ja active Active
- 2008-07-03 DK DK08773014.9T patent/DK2177217T3/en active
- 2008-07-03 US US12/667,915 patent/US9265752B2/en active Active
- 2008-07-03 WO PCT/CN2008/001267 patent/WO2009006787A1/zh not_active Ceased
- 2008-07-03 ES ES08773014.9T patent/ES2655705T3/es active Active
-
2016
- 2016-01-12 US US14/993,190 patent/US20160120822A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010532390A5 (enExample) | ||
| JP4883220B2 (ja) | ロチゴチン含有組成物及びその使用並びにこの組成物を含む経皮貼付剤 | |
| JP3984785B2 (ja) | パーキンソン症候群の治療のためのｄ２−アゴニスト含有経皮吸収治療システムおよびその製造方法 | |
| CA2785117C (en) | Transdermal therapeutic system for administering rivastigmine or derivatives thereof | |
| CN103476404B (zh) | 包含活性剂层和活性剂转化层的透皮组合物 | |
| US20070098772A1 (en) | Transdermal norelgestromin delivery system | |
| KR20060114338A (ko) | 경피 약물 전달 장치 | |
| JP2007511605A5 (enExample) | ||
| JP2011523650A5 (enExample) | ||
| TWI341735B (en) | Adhesive preparations | |
| JP4938949B2 (ja) | アセチルサリチル酸および／またはサリチル酸投与用の経皮治療システム | |
| JP2005154531A5 (enExample) | ||
| ITMI20012827A1 (it) | Formulazioni adesive transdermiche di diclofenac sodico | |
| JP7149951B2 (ja) | ニコチン含有透明経皮吸収治療システム | |
| KR20210065931A (ko) | 함수계 첩부제 | |
| JPH10265371A (ja) | 経皮吸収貼付剤 | |
| JP7354242B2 (ja) | イブプロフェンまたはその構造類似体を含む多層経皮薬物送達システム | |
| CA2494568A1 (en) | Patches containing tulobuterol | |
| JP6637883B2 (ja) | 経皮吸収型製剤 | |
| JP2002537257A5 (enExample) | ||
| JP3046330B2 (ja) | 貼付製剤 | |
| JP7337286B2 (ja) | アセナピン含有貼付剤 | |
| TWI809323B (zh) | 抑制阿申那平(asenapine)－n－氧化物之生成之方法 | |
| CN101843604A (zh) | 硝酸异山梨酯贴片及其制备方法 | |
| JPH1029934A (ja) | メラトニンを含有する貼付剤 |